Cervical cancer
Start with the big picture
The lesson connects persistent high-risk HPV infection with cervical cancer development and reviews behavioral and biological factors that can increase risk. It outlines HPV vaccination and routine screening as prevention and early-detection strategies, then introduces major histological subtypes and FIGO staging, including the significance of nodal metastasis. Management is organized by disease extent: early-stage options include surgery, with fertility-preserving approaches for selected patients; locally advanced disease commonly involves radiotherapy with concurrent chemotherapy; and recurrent or metastatic disease may be treated with systemic regimens. The topic also considers treatment-related toxicities, supportive care, and monitoring needs such as blood counts, renal function, electrolytes, blood pressure, and neuropathy.
What you'll learn
- Explain the role of persistent high-risk HPV infection in cervical cancer.
- Identify key risk factors and prevention strategies, including vaccination and screening.
- Describe the histological subtypes and staging concepts covered in the lesson.
- Compare treatment approaches for early-stage, locally advanced, and recurrent or metastatic disease.
- Recognize major treatment toxicities and relevant monitoring and supportive-care measures.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.